Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Bouillet

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 2017
Impairment of the Ability of HDL From Patients With Metabolic Syndrome but Without Diabetes Mellitus to Activate eNOS: Correction by S1P EnrichmentDamien Denimal, Serge Monier, Marie-Claude Brindisi, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 25, 2017
Liver Fat Content in People with Pituitary Diseases: Influence of Serum IGF1 LevelsAmandine Nguyen, Fréderic Ricolfi, Brivel Lemogne, et al.
European Journal of Endocrinology|June 23, 2020
Glucocorticoids impair HDL-mediated cholesterol efflux besides increased HDL cholesterol concentration: a proof of conceptBenjamin Bouillet, Thomas Gautier, Damien Denimal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 13, 2011
PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetesJean M Petit, Boris Guiu, David Masson, et al.
Cardiovascular Diabetology|May 4, 2023
Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetesDamien Denimal, Victoria Bergas, Jean-Paul Pais-de-Barros, et al.
Diabetes, Obesity & Metabolism|November 3, 2016
Glycaemic control influences the relationship between plasma PCSK9 and LDL cholesterol in type 1 diabetesStéphanie Laugier-Robiolle, Bruno Vergès, Maëlle Le Bras, et al.
Diabetes, Obesity & Metabolism|September 24, 2025
Plasma sphingolipids predict advanced liver fibrosis development in patients with type 2 diabetesSarah Béland-Bonenfant, Damien Denimal, Jean-Paul Pais-de-Barros, et al.
Journal of Clinical Medicine|February 11, 2023
Validation of the Fast-Track Model: A Simple Tool to Assess the Severity of Diabetic Foot UlcersMarco Meloni, Benjamin Bouillet, Raju Ahluwalia, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2010
Specifically PNPLA3-mediated accumulation of liver fat in obese patients with type 2 diabetesJean-Michel Petit, Boris Guiu, David Masson, et al.
Diabetes & Metabolism|July 25, 2025
Intact fish skin graft for deep diabetic foot ulcers: results from the KEREFISH randomized controlled trialDured Dardari, Louis Potier, Ariane Sultan, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Arteriosclerosis, Thrombosis, and Vascular Biology|April 1, 2017
Impairment of the Ability of HDL From Patients With Metabolic Syndrome but Without Diabetes Mellitus to Activate eNOS: Correction by S1P EnrichmentDamien Denimal, Serge Monier, Marie-Claude Brindisi, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 25, 2017
Liver Fat Content in People with Pituitary Diseases: Influence of Serum IGF1 LevelsAmandine Nguyen, Fréderic Ricolfi, Brivel Lemogne, et al.
European Journal of Endocrinology|June 23, 2020
Glucocorticoids impair HDL-mediated cholesterol efflux besides increased HDL cholesterol concentration: a proof of conceptBenjamin Bouillet, Thomas Gautier, Damien Denimal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 13, 2011
PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetesJean M Petit, Boris Guiu, David Masson, et al.
Cardiovascular Diabetology|May 4, 2023
Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetesDamien Denimal, Victoria Bergas, Jean-Paul Pais-de-Barros, et al.
Diabetes, Obesity & Metabolism|November 3, 2016
Glycaemic control influences the relationship between plasma PCSK9 and LDL cholesterol in type 1 diabetesStéphanie Laugier-Robiolle, Bruno Vergès, Maëlle Le Bras, et al.
Diabetes, Obesity & Metabolism|September 24, 2025
Plasma sphingolipids predict advanced liver fibrosis development in patients with type 2 diabetesSarah Béland-Bonenfant, Damien Denimal, Jean-Paul Pais-de-Barros, et al.
Journal of Clinical Medicine|February 11, 2023
Validation of the Fast-Track Model: A Simple Tool to Assess the Severity of Diabetic Foot UlcersMarco Meloni, Benjamin Bouillet, Raju Ahluwalia, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2010
Specifically PNPLA3-mediated accumulation of liver fat in obese patients with type 2 diabetesJean-Michel Petit, Boris Guiu, David Masson, et al.
Diabetes & Metabolism|July 25, 2025
Intact fish skin graft for deep diabetic foot ulcers: results from the KEREFISH randomized controlled trialDured Dardari, Louis Potier, Ariane Sultan, et al.
Pageof 8